KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Colgate Palmolive (CL) EBITDA (2016 - 2025)

Colgate Palmolive (CL) has 17 years of EBITDA data on record, last reported at $91.0 million in Q4 2025.

  • For Q4 2025, EBITDA fell 91.44% year-over-year to $91.0 million; the TTM value through Dec 2025 reached $3.3 billion, down 22.54%, while the annual FY2025 figure was $3.3 billion, 22.54% down from the prior year.
  • EBITDA reached $91.0 million in Q4 2025 per CL's latest filing, down from $1.1 billion in the prior quarter.
  • Across five years, EBITDA topped out at $1.1 billion in Q2 2024 and bottomed at $91.0 million in Q4 2025.
  • Average EBITDA over 5 years is $889.2 million, with a median of $1.0 billion recorded in 2021.
  • Peak YoY movement for EBITDA: skyrocketed 430.69% in 2023, then tumbled 91.44% in 2025.
  • A 5-year view of EBITDA shows it stood at $365.0 million in 2021, then crashed by 44.66% to $202.0 million in 2022, then surged by 430.69% to $1.1 billion in 2023, then fell by 0.84% to $1.1 billion in 2024, then crashed by 91.44% to $91.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $91.0 million in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.